PureTech Health (PRTC) Total Current Liabilities (2019 - 2025)
PureTech Health (PRTC) reported Total Current Liabilities of $46.3 million for Q4 2025, up 11.89% year-over-year from $41.4 million in Q4 2024, and up 14.13% quarter-over-quarter from $40.6 million in Q2 2025.
PureTech Health (PRTC) Total Current Liabilities (2019 - 2025) Analysis & Trends
PureTech Health (PRTC) has 7 years of Total Current Liabilities data on file, last reported at $46.3 million in Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $46.3 million, up 11.89% year-over-year; the trailing twelve-month figure through Dec 2025 was $46.3 million (up 11.89% YoY), and the FY2025 annual result was $46.3 million, up 11.89% from the prior year.
- Total Current Liabilities improved to $46.3 million in Q4 2025 per PRTC's latest filing, from $40.6 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $226.1 million in Q4 2021 and troughed at $40.6 million in Q2 2025.
- A 5-year average of $91.6 million and a median of $51.4 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Current Liabilities increased 24.99% in 2021, then tumbled 70.66% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $226.1 million in 2021, then sank by 57.16% to $96.9 million in 2022, then plunged by 46.98% to $51.4 million in 2023, then slipped by 19.43% to $41.4 million in 2024, then gained by 11.89% to $46.3 million in 2025.
- Business Quant data shows PRTC's Total Current Liabilities at $46.3 million in Q4 2025, $40.6 million in Q2 2025, and $41.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 46.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.31 Mn |
| Jun 30, 2025 | 40.58 Mn |
| Dec 31, 2024 | 41.39 Mn |
| Jun 30, 2024 | 138.31 Mn |
| Dec 31, 2023 | 51.37 Mn |
| Dec 31, 2022 | 96.89 Mn |
| Dec 31, 2021 | 226.14 Mn |
| Dec 31, 2020 | 180.92 Mn |
| Dec 31, 2019 | 139.20 Mn |